Among 6 sphingosine-1-phosphate (S1P) receptor modulators evaluated for use in patients with multiple sclerosis (MS), a new meta-analysis shows amiselimod had the highest efficacy. “This network ...

There are currently 2 widely accepted treatment strategies for MS: escalation and induction therapy. Escalation therapy begins with agents that are associated with less pronounced risk, but also may ...

National University of Singapore, Yong Loo Lin School of Medicine Multiple sclerosis (MS) is an autoimmune disease affecting the brain and spinal cord. In MS, the activated immune cells attack myelin, ...

Treatment with ozanimod (Zeposia) led to clinically meaningful improvement in cognitive processing speed among people with early relapsing multiple sclerosis (RMS), an ad hoc interim analysis of the ...